Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2023-07-13 | 2023-10-15 | 198473 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2020-09-30 | 2020-10-13 | 125332 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-06-20 | 2024-08-02 | 231010 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-09-12 | 2024-09-27 | 237360 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-10-18 | 2024-12-20 | 240613 |
| APO-BENZYDAMINE ORAL RINSE | 0.15% | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19087 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-09-04 | 2018-08-23 | 20860 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 67 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-09-09 | 2020-09-28 | 123892 |
| APO-BILASTINE TABLETS | 20MG | TABLET | Resolved | 2025-03-20 | 2025-04-11 | 253067 |
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-01-03 | 2018-09-09 | 34835 |
| APO-BISACODYL SUP 10MG | 10MG | SUPPOSITORY | Actual shortage | 2017-08-13 | 2017-10-05 | 18985 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2017-07-26 | 2017-12-14 | 17208 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2020-09-09 | 2020-10-05 | 123914 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2018-08-21 | 2019-01-02 | 58580 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2024-04-12 | 2024-07-19 | 225023 |
| APO-BISOPROLOL | 10MG | TABLET | Resolved | 2017-10-17 | 2017-12-04 | 26154 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2018-01-17 | 2018-04-09 | 36268 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2018-05-22 | 2018-07-17 | 50041 |
| APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | SOLUTION | Resolved | 2024-05-03 | 2024-05-10 | 227028 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |